drugset / Trial / NCT00363857

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

NCT00363857

Phase 3 Completed 360 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

A 14-Week clinical research study to compare the effectiveness and safety of ropinirole and placebo (an inactive sugar pill) in the treatment of patients with Restless Legs Syndrome (RLS) in the United States.

Timeline

Start
2003-08
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule